Clinical Trials

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

by ClinicalTrialsFeed • 2016/03/14 • 0 Comments

Status: Completed, Condition Summary: Keratoconjunctivitis Sicca

← VIDEO: Landscape of glaucoma treatment in transition

Inotek Pharmaceuticals to Present at GTCbio’s 8th Ocular Diseases and Drug Discovery Conference →